As expected, these mutations were nearly absent in cirrhotic and hepatitis tissues, corroborating the idea that CTNNB1 mutations typically arise later in the carcinogenic cascade and are rare in precursor lesions [32,36]. This evidence concerns the gene CTNNB1 and hepatitis A virus infection.